Chromatographic separation of silver-111 from neutron-irradiated palladium target: toward direct labeling of radiotracers
Authors (first, second and last of 10)
Volume 8, issue 1, December 2023
42 articles in this issue
-
-
Microfluidic-based production of [68Ga]Ga-FAPI-46 and [68Ga]Ga-DOTA-TOC using the cassette-based iMiDEVâ„¢ microfluidic radiosynthesizer
Authors (first, second and last of 10)
-
Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [68Ga]Ga-ABY-025 tracer
Authors (first, second and last of 11)
-
Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for 68Ga, 177Lu and 198Au
Authors (first, second and last of 13)
-
Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)
Authors (first, second and last of 8)
-
The Curies’ element: state of the art and perspectives on the use of radium in nuclear medicine
Authors (first, second and last of 4)
-
Evaluation of the 177mLu-concentration in in-house produced 177Lu-radiopharmaceuticals and commercially available Lutathera®
Authors (first, second and last of 6)
-
89Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations
Authors (first, second and last of 10)
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Authors (first, second and last of 22)
-
Bacterial survival in radiopharmaceutical solutions: a critical impact on current practices
Authors (first, second and last of 8)
-
Dosimetry of [18F]TRACK, the first PET tracer for imaging of TrkB/C receptors in humans
Authors (first, second and last of 12)
-
TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies
Authors (first, second and last of 15)
-
Synthesis and evaluation of a novel PET ligand, a GSK’963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain
Authors (first, second and last of 17)
-
Fully automated radiolabeling of [68Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging
Authors (first, second and last of 11)
-
Fully automated radiosynthesis of [68Ga]Ga-FAPI-46 with cyclotron produced gallium
Authors (first, second and last of 6)
-
-
Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?
Authors (first, second and last of 14)
-
Au@109Pd core–shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of 109Pd/109mAg in vivo generator in combined β− auger electron therapy
Authors (first, second and last of 6)
-
Good practices for the automated production of 18F-SiFA radiopharmaceuticals
Authors (first, second and last of 6)
This is part of 1 collection:
-
[225Ac]Ac- and [111In]In-DOTA-trastuzumab theranostic pair: cellular dosimetry and cytotoxicity in vitro and tumour and normal tissue uptake in vivo in NRG mice with HER2-positive human breast cancer xenografts
Authors (first, second and last of 5)
-
Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β
Authors (first, second and last of 16)
-
Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration
Authors (first, second and last of 6)
-
Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK
Authors (first, second and last of 6)
-
First-in-human study of a novel cell death tracer [99mTc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers
Authors (first, second and last of 11)
-
Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [225Ac]Ac-DOTA-TDA-Lipiodol® against hepatic tumors
Authors (first, second and last of 10)
-
In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer
Authors (first, second and last of 6)
-
-
-
-
Automated radiosynthesis and in vivo evaluation of 18F-labeled analog of the photosensitizer ADPM06 for planning photodynamic therapy
Authors (first, second and last of 11)
-
First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs
Authors (first, second and last of 10)
-
Intravenous and oral whole body ketone dosimetry, biodistribution, metabolite correction and kinetics studied by (R)-[1-11C]β-hydroxybutyrate ([11C]OHB) PET in healthy humans
Authors (first, second and last of 9)
-
Optimization of 177Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application
Authors (first, second and last of 5)
-
Membrane-based microfluidic solvent extraction of Ga-68 from aqueous Zn solutions: towards an automated cyclotron production loop
Authors (first, second and last of 7)
-
Site-specific 68Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models
Authors (first, second and last of 10)
-
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Authors (first, second and last of 21)
-
Synthesis of [18F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist’s perspective
Authors (first, second and last of 6)
-
Automated synthesis and quality control of [68Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging
Authors (first, second and last of 5)
-
Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression
Authors (first, second and last of 4)
-
Radiosynthesis and preclinical evaluation of [11C]SNX-ab as an Hsp90α,β isoform-selective PET probe for in vivo brain and tumour imaging
Authors (first, second and last of 5)
-
